Journal of the American Academy of Dermatology
Volume 53, Issue 3 , Pages 407-415 , September 2005

Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases

  • Timothy R. Coté, MD, MPH

      Affiliations

    • From the Food and Drug Administration, Center for Biologics Evaluation and Research
    • ,
  • Aparna K. Mohan, MD, PhD

      Affiliations

    • From the Food and Drug Administration, Center for Biologics Evaluation and Research
    • ,
  • Jacquelyn A. Polder, BSN, MPH

      Affiliations

    • From the Food and Drug Administration, Center for Biologics Evaluation and Research
    • ,
  • Marc K. Walton, MD, PhD

      Affiliations

    • Center for Drug Evaluation and Research
    • ,
  • M. Miles Braun, MD, MPH

      Affiliations

    • From the Food and Drug Administration, Center for Biologics Evaluation and Research
    • Corresponding Author InformationReprint requests: M. Miles Braun, MD, MPH, Food and Drug Administration, Center for Biologics Evaluation and Research, OBE 1401 Rockville Pike, HFM-220 Rockville, MD 20852.

,Accepted 5 June 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Coté is currently affiliated with the Centers for Disease Control and Prevention, Atlanta, Ga. Dr Mohan is currently affiliated with Johnson and Johnson, Philadelphia, Pa.Funding source: Food and Drug Administration, in furtherance of its mission of improving patient and consumer safety.Conflicts of interest: None identified.

PII: S0190-9622(05)01985-7

doi: 10.1016/j.jaad.2005.06.011

Journal of the American Academy of Dermatology
Volume 53, Issue 3 , Pages 407-415 , September 2005

Article Tools

* Image Usage & Resolution